ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 64 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $48,000 | -33.3% | 102,163 | -4.4% | 0.00% | -40.0% |
| Q4 2015 | $72,000 | -32.1% | 106,908 | -3.0% | 0.01% | -37.5% |
| Q3 2015 | $106,000 | -19.7% | 110,202 | 0.0% | 0.01% | -20.0% |
| Q2 2015 | $132,000 | +13.8% | 110,202 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $116,000 | -10.1% | 110,202 | -7.1% | 0.01% | -11.1% |
| Q4 2014 | $129,000 | -6.5% | 118,670 | -7.7% | 0.01% | 0.0% |
| Q3 2014 | $138,000 | +3.8% | 128,589 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $133,000 | +0.8% | 128,589 | -0.1% | 0.01% | 0.0% |
| Q1 2014 | $132,000 | -11.4% | 128,689 | -0.3% | 0.01% | -30.8% |
| Q4 2013 | $149,000 | -31.0% | 129,089 | 0.0% | 0.01% | -40.9% |
| Q3 2013 | $216,000 | -17.6% | 129,089 | -1.8% | 0.02% | -31.2% |
| Q2 2013 | $262,000 | – | 131,389 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
| MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
| Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| NEXT Financial Group, Inc | 60 | $0 | 0.00% |
| CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |